At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 81 enrolled
Drug / intervention
Intravenous acetaminophen +1 moredrug
Likely dose
Intravenous acetaminophen 1 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Multimodal Analgesic Regimen With Intravenous Acetaminophen to Standard Oral Multimodal Therapy in Primary Total Hip Arthroplasty: A Randomized Controlled Double Blind Trial
In Brief
A Phase 4 clinical trial evaluating Intravenous acetaminophen and Oral acetaminophen for Osteoarthritis and 2 related conditions. Completed, enrolled 81 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if intravenous acetaminophen is superior to oral acetaminophen when used as part of a multimodal pathway for primary total hip arthroplasty.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Acetaminophen, Arthroplasty, Hip Replacement
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedJul 2016
Enrollment StartMar 2017
Primary CompletionOct 2018
Study CompletionOct 2018
TodayJul 2026
First PostedJul 21, 2016
Enrollment StartMar 14, 2017
Primary CompletionOct 2, 2018
Study CompletionOct 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 9.9 years ago
Interventions
Intravenous acetaminophendrug
Subject receives 1 g acetaminophen by the intravenous route every 6 hours for 4 doses beginning in the preoperative holding area.
Oral acetaminophendrug
Subject receives 1 g acetaminophen by the oral route every 6 hours for 4 doses beginning in the preoperative holding area.